Citadel Advisors
CPIX icon

Citadel Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History

Citadel Advisors’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150K Buy
23,100
+10,600
+85% +$50.8K ﹤0.01% 12350
2026
Q1 		$40.6K Sell
12,500
-16,500
-57% -$63.6K ﹤0.01% 12485
2025
Q4 		$115K Buy
29,000
+7,700
+36% +$22.8K ﹤0.01% 11524
2025
Q3 		$66.5K Buy
+21,300
New +$70.8K ﹤0.01% 12063
2025
Q2 		– Sell
-6,800
Closed -$28.8K – 12859
2025
Q1 		$28.8K Buy
+6,800
New +$28.2K ﹤0.01% 12862
2024
Q3 		– Sell
-200
Closed -$306 – 14337
2024
Q2 		$306 Hold
200
– – ﹤0.01% 14036
2024
Q1 		$336 Sell
200
-5,500
-96% -$11K ﹤0.01% 14359
2023
Q4 		$9.92K Sell
5,700
-700
-11% -$1.28K ﹤0.01% 13133
2023
Q3 		$12.1K Buy
6,400
+4,300
+205% +$7.21K ﹤0.01% 12980
2023
Q2 		$3.09K Sell
2,100
-100
-5% -$173 ﹤0.01% 13722
2023
Q1 		$4.29K Buy
+2,200
New +$5.23K ﹤0.01% 13966

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citadel Advisors's CPIX Position: Q2 2026 in Review

Citadel Advisors increased its Cumberland Pharmaceuticals (CPIX) stake by 341% in Q2 2026, buying an estimated $272K and bringing the position to 73,391 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #9975.

Citadel Advisors first reported a position in CPIX in Q2 2013 and has held it in 19 quarters since. 32 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

  • Citadel Advisors held 73,391 shares of Cumberland Pharmaceuticals worth $476K as of Q2 2026.
  • Citadel Advisors bought 56,748 Cumberland Pharmaceuticals shares in Q2 2026, an estimated $272K.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #9975 holding.
  • Citadel Advisors first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 19 quarters since.
  • 32 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.